Clinical Trial Update: The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT [Phase 3]

View source ↗

Summary

Clinical trial update describing a Phase 3 study of induction gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma in the IMRT era; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING